City

Boston (1)

Rochester (1)

Condition

Recurrent Metastatic Melanoma (2)

Clinical Stage III Cutaneous Melanoma AJCC v8 (1)

Cutaneous Melanoma (1)

Melanoma (1)

Metastatic Melanoma (1)

Mucosal Melanoma (1)

Uveal Melanoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Mayo Clinic (1)

Collaborator

AstraZeneca (1)

Intervention

anti-pd-l1 monoclonal antibody imc-001 (1)

olaparib (1)

punch biopsy (1)

Study Documents

Intervention Type

biological (1)

drug (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

recurrent metastatic melanoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting

Clinical Stage III Cutaneous Melanoma AJCC v8
+3 more

Anti-PD-L1 Monoclonal Antibody IMC-001
Punch Biopsy

Rochester, Minnesota

Mayo Clinic in Rochester

Jan 4, 2023

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting

Recurrent Metastatic Melanoma
+3 more

Olaparib

Boston, Massachusetts
+1 more

Jul 29, 2022